M2-PK: detecting colonic polyps and cancer

Early detection of colonic polyps and their prompt removal is a fundamental goal of colorectal cancer screening and prevention. Results of a new multicentre study demonstrate sensitivity for the ScheBo M2-PK Quick test of 92.8% for bowel cancer and 69.4% for polyps. The ScheBo M2-PK Quick test detected twice as many bowel cancer cases and nearly six times the number of polyps compared with an immunological faecal occult blood test (FIT) also included in the study.

The ScheBo M2-PK Quick rapid test detects M2-PK, an innovative metabolic biomarker that is elevated in colorectal cancer, in faeces and is extremely easy to perform. The patient being screened simply collects a few grams from a single sample of formed stool, using the hygienic collection device provided. Laboratory results are obtained in just five minutes following completion of the simple stool extraction procedure using a ScheBo Quick-Prep device prefilled with buffer, which is supplied in the kit.
[email protected]

Other news

Upcoming Events


Technological University Dublin
3-4 September 2019

The Oxford Haematology in Obstetrics Postgraduate Course

St Edmund Hall, Queen's Lane, Oxford OX1 4AR
9-11 September 2019

IBMS Biomedical Science Congress

ICC, Birmingham
22-25 September 2019

Lab Innovations

NEC, Birmingham (Hall 12)
30 & 31 October 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Jun 2019

Recent advances in cancer diagnostics

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.